These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. An analysis of in vitro T cell responsiveness in nontuberculous mycobacterial infection. Tsuyuguchi I, Shiratsuchi H, Okuda Y, Yamamoto Y. Chest; 1988 Oct; 94(4):822-9. PubMed ID: 3262490 [Abstract] [Full Text] [Related]
3. [Responsiveness of lymphocytes from patients with M. avium-intracellulare complex (MAC) infection to PPDs as measured by IFN-gamma production]. Tomoda K, Yoneda T, Tsukaguchi K, Yoshikawa M, Tokuyama T, Fu A, Fukuoka K, Nakaya M, Narita N, Tasaka H. Kekkaku; 1994 May; 69(5):361-5. PubMed ID: 8007522 [Abstract] [Full Text] [Related]
4. Mycobacterium avium-Mycobacterium intracellular complex-induced suppression of T-cell proliferation in vitro by regulation of monocyte accessory cell activity. Tsuyuguchi I, Kawasumi H, Takashima T, Tsuyuguchi T, Kishimoto S. Infect Immun; 1990 May; 58(5):1369-78. PubMed ID: 1691144 [Abstract] [Full Text] [Related]
5. [Clinical immunology of tuberculosis]. Tsuyuguchi I. Kekkaku; 1990 Sep; 65(9):591-601. PubMed ID: 2232438 [Abstract] [Full Text] [Related]
6. [Tuberculin sensitivity to purified protein derivatives from Mycobacterium other than tuberculosis (PPD-B, PPD-Y, PPD-F and PPD-C) and PPDs among patients with mycobacteriosis--cooperative study of the Research Committee for the Mycobacteriosis in Japan]. Shigeto E, Tasaka H, Yamamoto M, Kataoka T, Haga S, Nagao S, Tajima H, Kurashima A, Aoyagi A, Wada R. Kekkaku; 1993 May; 68(5):351-60. PubMed ID: 8331879 [Abstract] [Full Text] [Related]
7. [Immunological studies of pulmonary infection with atypical mycobacteria. II. Depression of in vitro PPD-induced lymphocyte proliferation in patients with pulmonary atypical mycobacteriosis]. Harada Y, Ishibashi T, Harada S, Kitahara Y, Takamoto M, Shinoda A. Kekkaku; 1990 May; 65(5):341-8. PubMed ID: 2391797 [Abstract] [Full Text] [Related]
8. Defective T cell function for inhibition of growth of Mycobacterium avium-intracellulare complex (MAC) in patients with MAC disease: restoration by cytokines. Tsukaguchi K, Yoneda T, Okamura H, Tamaki S, Takenaka H, Okamoto Y, Narita N. J Infect Dis; 2000 Dec; 182(6):1664-71. PubMed ID: 11069238 [Abstract] [Full Text] [Related]
9. Cellular and humoral immunity to purified protein derivative (PPD) in PPD skin reactive and nonreactive patients with pulmonary tuberculosis: comparative analysis of antigen-specific lymphocyte proliferation and IgG antibodies. Boras Z, Juretić A, Rudolf M, Uzarević B, Trescec A. Croat Med J; 2002 Jun; 43(3):301-5. PubMed ID: 12035136 [Abstract] [Full Text] [Related]
11. [Purified protein derivatives prepared from Mycobacterium tuberculosis (PPDs) and M. intracellulare (PPD-B) in differential diagnosis of mycobacteriosis]. Shigeto E. Kekkaku; 1990 Nov; 65(11):701-9. PubMed ID: 2126050 [Abstract] [Full Text] [Related]
12. [Clinico-immunological study of the patients infected with Mycobacterium avium complex (MAC)]. Harada Y, Harada S, Kajiki A, Kitahara Y, Takamoto M, Ishibashi T, Shinoda A. Kekkaku; 1992 Jan; 67(1):71-81; discussion 83-4. PubMed ID: 1542210 [Abstract] [Full Text] [Related]
13. Cell-mediated immune response to tuberculosis antigens: comparison of skin testing and measurement of in vitro gamma interferon production in whole-blood culture. Katial RK, Hershey J, Purohit-Seth T, Belisle JT, Brennan PJ, Spencer JS, Engler RJ. Clin Diagn Lab Immunol; 2001 Mar; 8(2):339-45. PubMed ID: 11238218 [Abstract] [Full Text] [Related]
14. [Immunological studies in cases of pulmonary Mycobacterium avium complex infection without predisposing conditions]. Ochiai S, Harada Y, Harada S, Emori M, Kitahara Y, Takamoto M, Ishibashi T, Nakanishi Y, Hara N. Nihon Kokyuki Gakkai Zasshi; 2004 Mar; 42(3):232-8. PubMed ID: 15069779 [Abstract] [Full Text] [Related]
15. [Production of tumor necrosis factor alpha and interleukin-6 by peripheral monocytes from patients with atypical mycobacteriosis--relationship to clinical activity]. Tomoda K, Yoneda T, Tsukaguchi K, Yoshikawa M, Tokuyama T, Fu A, Fukuoka K, Nakaya M, Narita N, Tasaka H. Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Jun; 33(6):618-24. PubMed ID: 7666616 [Abstract] [Full Text] [Related]
16. Analysis of T cell subsets by monoclonal antibodies in patients with tuberculosis after in vitro stimulation with purified protein derivative of tuberculin. Shiratsuchi H, Tsuyuguchi I. Clin Exp Immunol; 1984 Aug; 57(2):271-8. PubMed ID: 6331920 [Abstract] [Full Text] [Related]
17. Spontaneous production of a suppressor factor by a human macrophage-like cell line U937. II. Suppression of antigen- and mitogen-induced blastogenesis, IL 2 production and IL 2 receptor expression in T lymphocytes. Fujiwara H, Toossi Z, Ohnishi K, Edmonds K, Ellner JJ. J Immunol; 1987 Jan 01; 138(1):197-203. PubMed ID: 3097146 [Abstract] [Full Text] [Related]
18. Lymphocyte-dependent inhibition of growth of virulent Mycobacterium tuberculosis H37Rv within human monocytes: requirement for CD4+ T cells in purified protein derivative-positive, but not in purified protein derivative-negative subjects. Silver RF, Li Q, Boom WH, Ellner JJ. J Immunol; 1998 Mar 01; 160(5):2408-17. PubMed ID: 9498784 [Abstract] [Full Text] [Related]
19. Different responses of monocytes and active T lymphocytes to in vitro challenge of purified protein derivative (PPD) in patients with active tuberculosis and healthy tuberculin reactors. Hsieh KH, Cheng RF. Ann Allergy; 1981 Mar 01; 46(3):159-63. PubMed ID: 6970534 [Abstract] [Full Text] [Related]
20. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants. Reitan LJ, Closs O, Belehu A. Int J Lepr Other Mycobact Dis; 1982 Dec 01; 50(4):455-67. PubMed ID: 6763003 [Abstract] [Full Text] [Related] Page: [Next] [New Search]